1 |
LI Y, XIA Y, YIN S, et al. Targeting Microglial alpha-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease[J]. Front Immunol, 2021,12:719807. doi:10.3389/fimmu.2021.719807
doi: 10.3389/fimmu.2021.719807
|
2 |
VIVEKANANTHAM S, SHAH S, DEWJI R, et al. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair[J]. Int J Neurosci, 2015,125(10):717-725. doi:10.3109/00207454.2014.982795
doi: 10.3109/00207454.2014.982795
|
3 |
MARCHELEK-MYSLIWIEC M, NALEWAJSKA M, TURON-SKRZYPINSKA A, et al. The Role of Forkhead Box O in Pathogenesis and Therapy of Diabetes Mellitus[J]. Int J Mol Sci, 2022,23(19):11611. doi:10.3390/ijms231911611
doi: 10.3390/ijms231911611
|
4 |
LUN P, JI T, WAN D H, et al. HOTTIP downregulation reduces neuronal damage and microglial activation in Parkinson's disease cell and mouse models[J]. Neural Regen Res, 2022,17(4):887-897. doi:10.4103/1673-5374.322475
doi: 10.4103/1673-5374.322475
|
5 |
胡梦妮, 张小蕾, 汪瑶, 等. 电针对鱼藤酮诱导帕金森模型大鼠p53通路机制研究[J]. 时珍国医国药, 2023,34(1):211-214.
|
6 |
李含章, 祁羚, 张小蕾, 等. 电针对帕金森模型小鼠GLP-1R介导的PI3K/AKT/GSK-3β信号通路的调控作用[J]. 实用医学杂志, 2021,37(21):2712-2716. doi:10.3969/j.issn.1006-5725.2021.21.003
doi: 10.3969/j.issn.1006-5725.2021.21.003
|
7 |
LEE E, HWANG I, PARK S, et al. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration[J]. Cell Death Differ, 2019,26(2):213-228. doi:10.1038/s41418-018-0124-5
doi: 10.1038/s41418-018-0124-5
|
8 |
ZHANG Q S, HENG Y, MOU Z, et al. Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease[J]. Acta Pharmacol Sin, 2017,38(10):1317-1328. doi:10.1038/aps.2017.49
doi: 10.1038/aps.2017.49
|
9 |
KAM T I, HINKLE J T, DAWSON T M, et al. Microglia and astrocyte dysfunction in parkinson's disease[J]. Neurobiol Dis, 2020,144:105028. doi:10.1016/j.nbd.2020.105028
doi: 10.1016/j.nbd.2020.105028
|
10 |
PAJARES M, I R A, MANDA G, et al. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications[J]. Cells, 2020,9(7):1687. doi:10.3390/cells9071687
doi: 10.3390/cells9071687
|
11 |
BADANJAK K, FIXEMER S, SMAJIC S, et al. The Contribution of Microglia to Neuroinflammation in Parkinson's Disease[J]. Int J Mol Sci, 2021,22(9):4676. doi:10.3390/ijms22094676
doi: 10.3390/ijms22094676
|
12 |
STEFANOVA N. Microglia in Parkinson's Disease[J]. J Parkinsons Dis, 2022,12(s1):S105-S112. doi:10.3233/jpd-223237
doi: 10.3233/jpd-223237
|
13 |
NGUYEN L, NGUYEN H D, KIM Y J, et al. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations[J]. J Parkinsons Dis, 2022,12(7):2117-2133. doi:10.3233/jpd-223290
doi: 10.3233/jpd-223290
|
14 |
JEWELL S, HERATH A M, GORDON R. Inflammasome Activation in Parkinson's Disease[J]. J Parkinsons Dis, 2022,12(s1):S113-S128. doi:10.3233/jpd-223338
doi: 10.3233/jpd-223338
|
15 |
WANG S, YUAN Y H, CHEN N H, et al. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease[J]. Int Immunopharmacol, 2019,67:458-464. doi:10.1016/j.intimp.2018.12.019
doi: 10.1016/j.intimp.2018.12.019
|
16 |
HAQUE M E, AKTHER M, JAKARIA M, et al. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease[J]. Mov Disord, 2020,35(1):20-33. doi:10.1002/mds.27874
doi: 10.1002/mds.27874
|
17 |
GORDON R, ALBORNOZ E A, CHRISTIE D C, et al. Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice[J]. Sci Transl Med, 2018,10(465):eaah4066. doi:10.1126/scitranslmed.aah4066
doi: 10.1126/scitranslmed.aah4066
|
18 |
LV Q K, TAO K X, WANG X B, et al. Role of alpha-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson's disease[J]. Inflamm Res, 2023,72(3):443-462. doi:10.1007/s00011-022-01676-x
doi: 10.1007/s00011-022-01676-x
|
19 |
JACOBS F M, VAN DER HEIDE L P, WIJCHERS P J, et al. FoxO6, a novel member of the FoxO class of transcription factors with distinct shuttling dynamics[J]. J Biol Chem, 2003,278(38):35959-35967. doi:10.1074/jbc.m302804200
doi: 10.1074/jbc.m302804200
|
20 |
DUMITRIU A, LATOURELLE J C, HADZI T C, et al. Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation[J]. PLoS Genet, 2012,8(6):e1002794. doi:10.1371/journal.pgen.1002794
doi: 10.1371/journal.pgen.1002794
|
21 |
RAY A, MARTINEZ B A, BERKOWITZ L A, et al. Mitochondrial dysfunction, oxidative stress, and neurodegeneration elicited by a bacterial metabolite in a C. elegans Parkinson's model[J]. Cell Death Dis, 2014,5(1):e984. doi:10.1038/cddis.2013.513
doi: 10.1038/cddis.2013.513
|
22 |
ZENG R, LUO D X, LI H P, et al. MicroRNA-135b alleviates MPP+-mediated Parkinson's disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis[J]. J Clin Neurosci, 2019,65:125-133. doi:10.1016/j.jocn.2019.04.004
doi: 10.1016/j.jocn.2019.04.004
|